NCT07317583Completed
Improving 5-Fluorouracil (5-FU) Continuous Infusion Comfort With a New Corset Design in People Affected by Cancer
Improving 5-Fluorouracil (5-FU) Continuous Infusion Comfort With a New Corset Design in People Affected by Cancer: A Feasibility Study
Source: ClinicalTrials.gov · Last updated 5 Jan 2026
Brief summary (registry, in English)
This feasibility randomized controlled trial aims to evaluate the effectiveness and usability of a newly designed supportive corset for patients receiving continuous 5-Fluorouracil (5-FU) infusion therapy. The corset is intended to stabilize the infusion pump and serum set, reduce physical and psychological discomfort, and improve overall quality of life. Forty colorectal cancer patients were randomized into two groups: an intervention group using the corset and a control group receiving standard care. Outcomes include infusion-related experiences (measured by Visual Analog Scale) and quality of life (assessed by EORTC QLQ-C30).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 30 Nov 2025
- Start date
- 10 Apr 2024
- Primary completion date
- 10 Dec 2024
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Colorectal cancer
- NCT number
- NCT07317583
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 10 Apr 2024 to the primary completion date, 10 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of brain cancer (excluded due to potential impact on cognitive function and reliability of self-reported data)
- Physician-diagnosed mental illness
Other
- Presence of bone metastases
- Pregnancy and/or lactation
- Communication barriers
- Inability to speak or understand Turkish
Who the study is looking for
- Diagnosed with colorectal cancer
- Currently receiving chemotherapy
- Having received at least one cycle of 5-FU therapy via continuous infusion
- Volunteering to participate in the study
- Aged 18 years or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| İstanbul University-Cerrahpaşa Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.